127 related articles for article (PubMed ID: 33545070)
41. p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX.
Levy R; Gregory E; Borcherds W; Daughdrill G
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30832340
[TBL] [Abstract][Full Text] [Related]
42. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
[TBL] [Abstract][Full Text] [Related]
43. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
[TBL] [Abstract][Full Text] [Related]
44. Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications.
Bah A; Forman-Kay JD
J Biol Chem; 2016 Mar; 291(13):6696-705. PubMed ID: 26851279
[TBL] [Abstract][Full Text] [Related]
45. Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins.
Thomae AW; Pich D; Brocher J; Spindler MP; Berens C; Hock R; Hammerschmidt W; Schepers A
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1692-7. PubMed ID: 18234858
[TBL] [Abstract][Full Text] [Related]
46. HMGA1a protein unfolds or refolds synthetic DNA-chromophore hybrid polymers: a chaperone-like behavior.
Wan W; Wang W; Li AD
Chembiochem; 2008 Jan; 9(2):304-11. PubMed ID: 18067116
[TBL] [Abstract][Full Text] [Related]
47. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
Okuda M; Nishimura Y
J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
[TBL] [Abstract][Full Text] [Related]
48. Extensive post-translational modification of active and inactivated forms of endogenous p53.
DeHart CJ; Chahal JS; Flint SJ; Perlman DH
Mol Cell Proteomics; 2014 Jan; 13(1):1-17. PubMed ID: 24056736
[TBL] [Abstract][Full Text] [Related]
49. Real-time surface plasmon resonance monitoring of site-specific phosphorylation of p53 protein and its interaction with MDM2 protein.
Wu L; He Y; Hu Y; Lu H; Cao Z; Yi X; Wang J
Analyst; 2019 Oct; 144(20):6033-6040. PubMed ID: 31502598
[TBL] [Abstract][Full Text] [Related]
50. HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA.
Manabe T; Ohe K; Katayama T; Matsuzaki S; Yanagita T; Okuda H; Bando Y; Imaizumi K; Reeves R; Tohyama M; Mayeda A
Genes Cells; 2007 Oct; 12(10):1179-91. PubMed ID: 17903177
[TBL] [Abstract][Full Text] [Related]
51. Molecular biosensing system based on intrinsically disordered proteins.
Cissell KA; Shrestha S; Purdie J; Kroodsma D; Deo SK
Anal Bioanal Chem; 2008 Jul; 391(5):1721-9. PubMed ID: 18193204
[TBL] [Abstract][Full Text] [Related]
52. VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage.
López-Sánchez I; Valbuena A; Vázquez-Cedeira M; Khadake J; Sanz-García M; Carrillo-Jiménez A; Lazo PA
FEBS Lett; 2014 Mar; 588(5):692-700. PubMed ID: 24492002
[TBL] [Abstract][Full Text] [Related]
53. Intrinsic disorder in proteins: a challenge for (un)structural biology met by ion mobility-mass spectrometry.
Jurneczko E; Cruickshank F; Porrini M; Nikolova P; Campuzano ID; Morris M; Barran PE
Biochem Soc Trans; 2012 Oct; 40(5):1021-6. PubMed ID: 22988858
[TBL] [Abstract][Full Text] [Related]
54. An acetyl-methyl switch drives a conformational change in p53.
Tong Q; Mazur SJ; Rincon-Arano H; Rothbart SB; Kuznetsov DM; Cui G; Liu WH; Gete Y; Klein BJ; Jenkins L; Mer G; Kutateladze AG; Strahl BD; Groudine M; Appella E; Kutateladze TG
Structure; 2015 Feb; 23(2):322-31. PubMed ID: 25651062
[TBL] [Abstract][Full Text] [Related]
55. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.
Craig A; Scott M; Burch L; Smith G; Ball K; Hupp T
EMBO Rep; 2003 Aug; 4(8):787-92. PubMed ID: 12897801
[TBL] [Abstract][Full Text] [Related]
56. Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro.
Sheppard HM; Liu X
Anticancer Res; 1999; 19(3A):2079-83. PubMed ID: 10470151
[TBL] [Abstract][Full Text] [Related]
57. Novel interaction between HMGA1a and StIP1 in murine terminally differentiated retina.
Okuda H; Manabe T; Yanagita T; Matsuzaki S; Bando Y; Katayama T; Wanaka A; Tohyama M
Mol Cell Neurosci; 2006 Sep; 33(1):81-7. PubMed ID: 16870469
[TBL] [Abstract][Full Text] [Related]
58. Induced HMGA1a expression causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease.
Manabe T; Katayama T; Sato N; Gomi F; Hitomi J; Yanagita T; Kudo T; Honda A; Mori Y; Matsuzaki S; Imaizumi K; Mayeda A; Tohyama M
Cell Death Differ; 2003 Jun; 10(6):698-708. PubMed ID: 12761578
[TBL] [Abstract][Full Text] [Related]
59. Tissues tell the real tale of breast cancer.
Cottingham K
J Proteome Res; 2007 Jun; 6(6):2052. PubMed ID: 17577952
[No Abstract] [Full Text] [Related]
60. How multisite phosphorylation impacts the conformations of intrinsically disordered proteins.
Jin F; Gräter F
PLoS Comput Biol; 2021 May; 17(5):e1008939. PubMed ID: 33945530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
